| Revenue growth | 162% YoY revenue growth to ₹314cr driven by US acquisition. |
|---|---|
| Margins | EBITDA margins improving post-integration; targeting 18-20% blended range. |
| Demand visibility | Strong traction in US oilfields and recovery in apparel exports. |
| Management confidence | Extremely high, focusing on doubling US capacity and global expansion. |
Growth
Revenue grew 162% to ₹314cr; PAT rose 118% to ₹44cr. Growth is inorganic-heavy but scaling fast.
Outlook
CCT business targeted to reach $200M revenue by FY28 with 15% EBITDA margins.
Risks
Integration risk of CCT Group and geopolitical disruptions to global shipping/logistics remain primary concerns.
Earnings Call filed with BSE, NSE: FCL. Summary written with AI assistance from the document.
Fineotex Chemical Ltd: key numbers
- Share price
- ₹60.48
- Market cap
- ₹7,043 Cr
- Revenue (annual)
- ₹772.2 Cr
- Net profit (annual)
- ₹108.8 Cr
- P/E (TTM)
- 57.6×Sector 37.5×
- Promoter holding
- 62.30%+0.00% QoQ
- FII holding
- 3.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fineotex Chemical Ltd
All →Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new US-based subsidiary, Fineotex America Inc., for ₹0.05 Crore to provide specialized water treatment solutions.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical's FZE subsidiary incorporated Fineotex America Inc. in Delaware, USA. The entity will supply water treatment chemicals for data centers and semiconductors.
Fineotex Chemical Annual General Meeting
Fineotex Chemical Limited conducted its 23rd Annual General Meeting on September 11, 2026. Shareholders discussed ordinary and special business items, including dividend and fund raising proposals.
Fineotex Chemical Earnings Call Transcript: Key Takeaways
Fineotex delivered a massive 165% revenue surge driven by the full consolidation of its US-based oil and gas subsidiary, CrudeChem. Management is aggressively pivoting from textiles toward high-margin US energy markets.
- Call
- Guides 100% growth
Fineotex Chemical Investor Presentation: Key Takeaways
Fineotex (FCL) presents its Q1 FY27 performance, highlighting its evolution into a diversified specialty chemical powerhouse with significant expansion into the US oil and gas sector through CrudeChem.
Fineotex Chemical Earnings Call: Key Takeaways
Fineotex Chemical reports 162% revenue growth to ₹314cr in Q4FY26, driven by the CrudeChem acquisition and strong specialty textile chemical demand.